EnerSys (ENS) is little changed in Monday's trading as BTIG upgraded shares to Buy from Neutral with a $175 price target, ...

Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 25% in morning trade. The trial results set the ...

In this post, we’ll highlight a few of our favorite visuals from 2025 and walk through how we made them and what makes them ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

Circle has experienced extreme stock volatility, rising nearly 10x post-IPO before retracing sharply as valuation concerns ...

New findings reveal why skills-based hiring is growing more slowly than expected and how employers are balancing degrees, ...

A Thai government agency has kicked off a campaign calling for a transition to a plant-rich food system, citing better health ...

Seasoned economic development expert returns to help drive data informed growth and competitiveness in Southern NevadaLAS VEGAS, Dec. 15, 2025 ...